Sabra Health Valuation
| SBC Stock | EUR 17.88 0.05 0.28% |
At this time, the company appears to be fairly valued. Sabra Health Care has a current Real Value of €17.33 per share. The regular price of the company is €17.88. Our model measures the value of Sabra Health Care from inspecting the company fundamentals such as Operating Margin of 0.27 %, shares outstanding of 231.16 M, and Return On Equity of -0.0241 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Sabra Health's price fluctuation is very steady at this time. Calculation of the real value of Sabra Health Care is based on 3 months time horizon. Increasing Sabra Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sabra stock is determined by what a typical buyer is willing to pay for full or partial control of Sabra Health Care. Since Sabra Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sabra Stock. However, Sabra Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.88 | Real 17.33 | Hype 17.88 |
The real value of Sabra Stock, also known as its intrinsic value, is the underlying worth of Sabra Health Care Company, which is reflected in its stock price. It is based on Sabra Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sabra Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sabra Health Care helps investors to forecast how Sabra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sabra Health more accurately as focusing exclusively on Sabra Health's fundamentals will not take into account other important factors: Sabra Health Total Value Analysis
Sabra Health Care is at this time estimated to have takeover price of 5.1 B with market capitalization of 2.59 B, debt of 2.31 B, and cash on hands of 56.81 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sabra Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.1 B | 2.59 B | 2.31 B | 56.81 M |
Sabra Health Investor Information
About 90.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Health Care recorded a loss per share of 0.33. The entity last dividend was issued on the 10th of February 2023. Based on the key indicators obtained from Sabra Health's historical financial statements, Sabra Health Care is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Sabra Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sabra Health has an asset utilization ratio of 10.87 percent. This implies that the Company is making €0.11 for each dollar of assets. An increasing asset utilization means that Sabra Health Care is more efficient with each dollar of assets it utilizes for everyday operations.Sabra Health Ownership Allocation
Sabra Health Care shows a total of 231.16 Million outstanding shares. The majority of Sabra Health Care outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sabra Health to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sabra Health Care. Please pay attention to any change in the institutional holdings of Sabra Health Care as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sabra Health Profitability Analysis
The company reported the revenue of 624.81 M. Net Loss for the year was (77.61 M) with profit before overhead, payroll, taxes, and interest of 372.8 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sabra Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sabra Health and how it compares across the competition.
About Sabra Health Valuation
The stock valuation mechanism determines Sabra Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sabra Health. We calculate exposure to Sabra Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sabra Health's related companies.As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada
8 Steps to conduct Sabra Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sabra Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sabra Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sabra Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sabra Health's revenue streams: Identify Sabra Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sabra Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sabra Health's growth potential: Evaluate Sabra Health's management, business model, and growth potential.
- Determine Sabra Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sabra Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Sabra Stock analysis
When running Sabra Health's price analysis, check to measure Sabra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Health is operating at the current time. Most of Sabra Health's value examination focuses on studying past and present price action to predict the probability of Sabra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Health's price. Additionally, you may evaluate how the addition of Sabra Health to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |